ArticleLiver cancer2023

Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial.

Zhenggang Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.